Platelet-rich plasma, shockwave therapy show therapeutic efficacy in interstitial cystitis
For patients with interstitial cystitis (IC)/bladder pain syndrome (BPS), the combination of platelet-rich plasma (PRP) and low-intensity extracorporeal shock wave therapy (LI-ESWT) shows therapeutic efficacy, according to a study recently published in Frontiers in Bioengineering and Biotechnology.
<p>For patients with interstitial cystitis (IC)/bladder pain syndrome (BPS), the combination of platelet-rich plasma (PRP) and low-intensity extracorporeal shock wave therapy (LI-ESWT) shows therapeutic efficacy, according to a study recently published in Frontiers in Bioengineering and Biotechnology.</p>